Profiling for novel proteomics biomarkers in neurodevelopmental disorders

Area of Science:

• Biomarker Discovery
• Neuroscience
• Proteomics

Background:

• Protein biomarker discovery in biological fluids (e.g., serum) is established for cancers and some neuropsychiatric disorders (e.g., Alzheimer's disease, schizophrenia).
• Application of these technologies for neurodevelopmental disorders, including autism spectrum disorder (ASD) and attention deficit hyperactivity disorder (ADHD), is less developed.
• Identifying reliable protein biomarkers is crucial for early diagnosis and targeted treatments.

Purpose of the Study:

• To provide an overview of available protocols for protein biomarker analysis in neurodevelopmental disorders.
• To discuss existing studies on protein biomarker discovery and validation in this population.
• To consider future directions and advancements in the field.

Main Methods:

• Review of existing literature and protocols for proteomic analysis of biological fluids.
• Analysis of published studies focusing on biomarker discovery in neurodevelopmental disorders.
• Discussion of technological advancements and challenges.

Main Results:

• The field of protein biomarker discovery for neurodevelopmental disorders is comparatively less established than for other conditions.
• Various proteomic techniques are available, but their application and validation in neurodevelopmental disorders require further research.
• Existing studies show promise but highlight the need for standardized protocols and larger cohorts.

Conclusions:

• Further research and development of standardized proteomic protocols are essential for advancing biomarker discovery in neurodevelopmental disorders.
• Protein biomarkers hold significant potential for improving diagnosis and understanding of conditions like ASD and ADHD.
• Interdisciplinary collaboration and technological innovation will drive future progress in this research area.